FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/10/095649 [Registered on: 06/10/2025] Trial Registered Prospectively
Last Modified On: 03/10/2025
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Cross Sectional Study 
Study Design  Single Arm Study 
Public Title of Study   How do children and adolescents with features of Attention deficit/hyperactivity disorder manage emotions, think and understand social situations 
Scientific Title of Study   Social functioning in children and adolescents with ADHD traits: the role of Emotional Regulation, Executive functions and Social cognition as mediators: An observational study 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Insiya Patanwala 
Designation  Junior Resident, M.D. Psychiatry 
Affiliation  Kasturba Medical College, MAHE, Manipal 
Address  Department of Psychiatry, Kasturba Medical College, MAHE, Manipal, Udupi

Udupi
KARNATAKA
576104
India 
Phone  8369115352  
Fax    
Email  patanwala.kmcmpl2024@learner.manipal.edu  
 
Details of Contact Person
Scientific Query
 
Name  Dr Savitha Soman 
Designation  Professor and HOD, Department of Psychiatry 
Affiliation  Kasturba Medical College, MAHE, Manipal 
Address  Department of Psychiatry, Kasturba Medical College, MAHE, Manipal, Udupi

Udupi
KARNATAKA
576104
India 
Phone  9845240653  
Fax    
Email  savitha.soman@manipal.edu  
 
Details of Contact Person
Public Query
 
Name  Dr Insiya Patanwala 
Designation  Junior resident, M.D. Psychiatry 
Affiliation  Kasturba Medical College, MAHE, Manipal 
Address  Department of Psychiatry, Kasturba Medical College, Manipal, Udupi

Udupi
KARNATAKA
576104
India 
Phone  8369115352  
Fax    
Email  patanwala.kmcmpl2024@learner.manipal.edu  
 
Source of Monetary or Material Support  
Department of Psychiatry, Kasturba Medical College, MAHE, Madhav Nagar, Near Tiger circle, Manipal - 576104, Karnataka, India 
 
Primary Sponsor  
Name  Dr Insiya patanwala 
Address  The Department of Psychiatry, Kasturba Medical College, Tiger circle, Madhav Nagar, Manipal, Udupi, Karnataka 576104 
Type of Sponsor  Other [self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Insiya Patanwala  Kasturba Medical College  Department of Psychiatry, Kasturba Medical College, MAHE, Tiger Circle, Madhav Nagar, Manipal, Udupi, Karnataka - 576104, India
Udupi
KARNATAKA 
8369115352

patanwala.kmcmpl2024@learner.manipal.edu 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
KMC and KH Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: F90-F98||Behavioral and emotional disorders with onset usually occurring in childhood and adolescence,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Nil  Nil 
Intervention  Nil  Nil 
Intervention  Nil  Nil 
 
Inclusion Criteria  
Age From  11.00 Day(s)
Age To  17.00 Year(s)
Gender  Both 
Details 
1. ADHD traits present as measured by DSM 5 criteria, more than 4 symptoms in inattention domain and or more than 4 symptoms in hyperactivity or impulsivity domain.
2. Age of participants between 11 and 17 years and of any gender.
3. Seeking consultation under the Department of Psychiatry, KMC, Manipal.
4. Informed consent taken from parents.
5. Informed assent taken from adolescents, verbal assent from 11 to 12 years old and written assent from above 12 years old.
6. Minimum education of parents to be till primary school.
7. Parents and adolescents can speak and read English, Kannada or Hindi.
 
 
ExclusionCriteria 
Details  1. Clinically diagnosed with moderate to severe mood disorders, anxiety disorders, personality disorders and psychotic spectrum disorders (as per DSM 5 TR level 1 cross cutting symptom measure for 11-17 years)
2. Clinically diagnosed with syndromal ASD, IDD using behavioural indicators of ICD11. (all levels of severity).
3. Any acute/ chronic medical condition that will impact their current emotional state like chronic pain conditions, endocrine disorders, neurological conditions such as uncontrolled seizure disorder.
4. Refusal to assent/consent for the study.
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
ADHD traits will be identified using DSM-5 criteria (more than 4 symptoms in either inattention or hyperactivity/impulsivity)  18 months 
 
Secondary Outcome  
Outcome  TimePoints 
Parents’ interview: SWAN ADHD, SDQ, and ICF Core Sets Interview

Children’s assessment: DERS-16, PEBL software tasks, and Faux Pas Recognition Test  
18 months 
 
Target Sample Size   Total Sample Size="145"
Sample Size from India="145" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   14/10/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  31/07/2027 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   1. Approval will be obtained from the Department of Scientific Committee and Institutional Ethics Committee of KMC, and the study will be registered at the Clinical Trial Registry of India.
2. Participants will be recruited after IEC clearance based on predefined inclusion and exclusion criteria, with informed consent from parents and assent from adolescents.
3. Participants meeting criteria for significant ADHD traits will undergo assessment of key study variables.
4. Parents will provide sociodemographic information and complete the SWAN ADHD and Strengths and difficulties questionnaire, and participate in an interview to assess the child’s social functioning.
5. Children and adolescents will complete the DERS-16, PEBL tests, and the Faux Pas Recognition Test to assess emotional regulation, executive function, and social cognition.
6. Data collection will follow strict ethical guidelines, with all information kept confidential.
7. Statistical analyses will be performed to explore relationships between study variables and test hypotheses.
 
Close